UW Medicine announced on Monday that a new mRNA influenza vaccine is now available for adults aged 50 and older in Seattle. The vaccine is described as more effective for this age group as the flu season approaches.
The rollout targets residents of Seattle, Washington, offering a novel mRNA‑based option for older adults seeking protection against influenza.